Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery

Metabolism: Clinical and Experimental

Volumn 58, Issue 6, 2009, Pages 753-758

  Heath, Madeleine L ^a   Kow, Lilian ^a   Slavotinek, John P ^a   Valentine, Robin ^a   Toouli, Jim ^a   Thompson, Campbell H ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LIPID;

ABDOMINAL OBESITY; ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAT INTAKE; FATTY ACID BLOOD LEVEL; FATTY LIVER; FEMALE; GASTRIC BANDING; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID LIVER LEVEL; LIPID STORAGE; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; WEIGHT REDUCTION;

ABDOMINAL FAT; ADIPOSITY; ADULT; BARIATRIC SURGERY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OBESITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65549125833     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.05.021     Document Type: Article

References (32)

1. Arner P. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 14 (2003) 137-145
2. Ross R., Dagnone D., Jones P.J., Smith H., Paddags A., Hudson R., et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 133 (2000) 92-103
3. Busetto L., Tregnaghi A., Bussolotto M., Sergi G., Beninca P., Ceccon A., et al. Visceral fat loss evaluated by total body magnetic resonance imaging in obese women operated with laparoscopic adjustable silicone gastric banding. Int J Obes Relat Metab Disord 24 (2000) 60-69
4. Laaksonen D., Kainulainen S., Rissanen A., and Niskanen L. Relationships between changes in abdominal fat distribution and insulin sensitivity during a very low calorie diet in abdominally obese men and women. Nutr Metab Cardiovasc Dis 13 (2003) 349-356
5. Arner P. Catecholamine-induced lipolysis in obesity. Int J Obes Relat Metab Disord 23 Suppl 1 (1999) 10-13
6. Wahlroos S., Phillips M.L., Lewis M.C., Kow L., Toouli J., Slavotinek J.P., et al. Rapid significant weight loss and regional lipid deposition: implications for insulin sensitivity. Obes Res Clin Pract 1 (2007) 7-16
7. Giorgino F., Laviola L., and Eriksson J.W. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand 183 (2005) 13-30
8. Goodpaster B.H., Kelley D.E., Wing R.R., Meier A., and Thaete F.L. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48 (1999) 839-847
9. Janssen I., Fortier A., Hudson R., and Ross R. Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 25 (2002) 431-438
10. Thorne A., Lonnqvist F., Apelman J., Hellers G., and Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes 26 (2002) 193-199
11. Klein S., Fontana L., Young V.L., Coggan A.R., Kilo C., Patterson B.W., et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350 (2004) 2549-2557
12. Giugliano G., Nicoletti G., Grella E., Giugliano F., Esposito K., Scuderi N., et al. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg 57 (2004) 190-194
13. Seppala-Lindroos A., Vehkavaara S., Hakkinen A.M., Goto T., Westerbacka J., Sovijarvi A., et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87 (2002) 3023-3028
14. Thomas E.L., Hamilton G., Patel N., O'Dwyer R., Dore C.J., Goldin R.D., et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 54 (2005) 122-127
15. Thomsen C., Becker U., Winkler K., Christoffersen P., Jensen M., and Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12 (1994) 487-495
16. Longo R., Ricci C., Masutti F., Vidimari R., Croce L.S., Bercich L., et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 28 (1993) 297-302
17. Szczepaniak L.S., Nurenberg P., Leonard D., Browning J.D., Reingold J.S., Grundy S., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288 (2005) E462-E468
18. Phillips M.L., Lewis M.C., Chew V., Kow L., Slavotinek J.P., Daniels L., et al. The early effects of weight loss surgery on regional adiposity. Obes Surg 15 (2005) 1449-1455
19. Thomas E.L., and Bell J.D. Influence of undersampling on magnetic resonance imaging measurements of intra-abdominal adipose tissue. Int J Obes 27 (2003) 211-218
20. Matthews D., Hosker J., Rudenski A., Naylor B., Treacher D., and Turner R. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
21. Bonora E., Targher G., Alberiche M., Bonadonna R., Saggiani F., Zenere M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23 (2000) 57-63
22. Katsuki A., Sumida Y., Gabazza E.C., Murashima S., Furuta M., Araki-Sasaki R., et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 24 (2001) 362-365
23. Emoto M., Nishizawa Y., Maekawa K., Hiura Y., Kanda H., Kawagishi T., et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22 (1999) 818-822
24. Dixon J.B., Dixon A.F., and O'Brien P.E. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Diabet Med 20 (2003) 127-134
25. Westerbacka J., Lammi K., Hakkinen A.M., Rissanen A., Salminen I., Aro A., et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90 (2005) 2804-2809
26. Gray D.S., Fujioka K., Colletti P.M., Kim H., Devine W., Cuyegkeng T., et al. Magnetic-resonance-imaging used For determining fat distribution in obesity and diabetes. Am J Clin Nutr 54 (1991) 623-627
27. Zamboni M., Armellini F., Turcato E., Todesco T., Bissoli L., Bergamoandreis I.A., et al. Effect of weight-loss on regional body-fat distribution in premenopausal women. Am J Clin Nutr 58 (1993) 29-34
28. Pontiroli A., Pizzocri P., Librenti M., Vedani P., Marchi M., Cucchi E., et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87 (2002) 3555-3561
29. Leenen R., Van Der Kooy K., Deurenberg P., Seidell J.C., Weststrate J.A., Schouten J.M., et al. Visceral fat accumulation in obese subjects: relation to energy expenditure and response to weight loss. Am J Physiol Endocrinol Metab 263 (1992) E913-E919
30. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
31. Brochu M., Tchernof A., Turner A.N., Ades P.A., and Poehlman E.T. Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women?. Metabolism 52 (2003) 599-604
32. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223